Should pregnant women be vaccinated against COVID-19?
A recent review in the journal Vaccines examines whether coronavirus disease 2019 (COVID-19) risks in pregnant women justify the rare
Read more
J&J COVID-19 booster shot produces robust antibody response
The coronavirus disease (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread across the
Read more
Analysis of antibody titer decay following vaccination or SARS-CoV-2 infection
The ongoing coronavirus disease 2019 (COVID-19) pandemic has severely impacted the world’s healthcare system and economy. COVID-19, which is caused
Read more
Hot spots where covid vaccination lags push experimental antibody treatment
For months, Joelle Ruppert was among the millions of Americans who are covid vaccine holdouts. Her reluctance, she said, was
Read more
SARS-CoV-2 Delta variant associated with more breakthrough infections
A US-based study conducted in the National Capital Region has recently compared the infectious virus loads in vaccinated and unvaccinated
Read more
Delta variant unable to evade antibodies elicited by COVID-19 vaccination, finds study
Despite causing a surge in infections this summer that has resulted in thousands of hospitalizations and deaths, the delta variant
Read more
Study of antibody responses to COVID-19 mRNA vaccine in convalescent individuals
In the midst of a COVID-19 pandemic well into its second year, most developed countries are implementing effective severe acute
Read more
Scientists urge increased attention to persistent COVID-19 infections in immunocompromised people
In an article in the New England Journal of Medicine, scientists from Fred Hutchinson Cancer Research Center, Johns Hopkins Bloomberg
Read more
Antibody levels remain high nine months after SARS-CoV-2 infection, study shows
Testing of an entire Italian town shows antibody levels remain high nine months after SARS-CoV-2 infection, whether symptomatic or asymptomatic.
Read more
REGEN-COV antibody cocktail shown to significantly lower SARS-CoV-2 viral load
The phase 1/2 trial of the REGEN-COV (casirivimab and imdevimab) antibody cocktail from Regeneron conducted on 799 individuals shows that
Read more